drugset / Trial / NCT00126100

Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)

NCT00126100

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether stem cell mobilization by granulocyte colony-stimulating factor (G-CSF) therapy in patients with acute myocardial infarction after successful mechanical reperfusion reduces infarct size.

Timeline

Start
2004-02
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Granulocyte colony-stimulating factor Protein / enzyme biologic 10 ug/kg Subcutaneous

Indications